Measles, mumps and rubella outbreaks still represent an healthcare issue, even though major advancements have been done towards their eradication. A poor inclination towards Mmr (measles-mumps-rubella) vaccination may constitute a major cause of increased risk to contract one of these diseases amongst specific population groups like migrants, alternative medicine users, some religious groups, healthcare professionals.
Information on Mmr vaccines coverage amongst these and others “hard-to-reach” groups was included in a document made and published Ecdc in range of the European project Venice II (Vaccine European New Integrated Collaboration Effort II). Main aim of the document was to provide a complete review of measles, mumps and rubella focuses which have been reported in the last twenty years in Europe.
An update on Mmr
Primary tabs
Autori:
Sezioni:
Indice:
Vaccination
prossimo articolo
Horizon 2020: now's the time
Horizon 2020 finally goes into the executive phase. It is the new European funding system for research and innovation, that is now replacing the seventh Framework Programme (FP7), ended in December 2013.
Therefore, European research has to face new opportunities as well as new rules, new issues and new administrative and normative challenges. With about 30 research institutions located in its territory, Trieste is a peculiar site in Europe both for basic research and for innovation and technology transfer.